Barinthus Biotherapeutics plc. 3 SEC Filings

Filed On	Filing
01 May 2026	Form 3: Swirsky Douglas J, Principal Accounting Officer No securities owned
20 Dec 2024	Form 3: Lynn Geoffrey, Chief Scientific Officer Holds 638,442 shares of Ordinary Shares
18 Jun 2024	Form 3: Hooftman Leon, Chief Medical Officer No securities owned
24 Feb 2023	Form 3: Pelletier Nadege, Chief Scientific Officer No securities owned
23 Sep 2022	Form 3: Brown Gemma, Chief Financial Officer
05 Nov 2021	Form 3: M&G Alternatives Investment Management Ltd, 10% owner Holds 4,108,752 shares of American Depositary Shares
03 May 2021	Form 3: M&G Investment Management Ltd, 10% owner Holds 963,597 shares of American Depositary Shares
29 Apr 2021	Form 3: Oxford Sciences Innovation plc, 10% owner
29 Apr 2021	Form 3: Scheeren Joseph, Director No securities owned
29 Apr 2021	Form 3: Phillips Anne M., Director No securities owned
29 Apr 2021	Form 3: Morgon Pierre A., Director Holds 10,506 shares of Ordinary Shares
29 Apr 2021	Form 3: Marshall Margaret, Chief Medical Officer
29 Apr 2021	Form 3: Hammacher Alex, Director No securities owned
29 Apr 2021	Form 3: Wright Robin, Director Holds 10,506 shares of Ordinary Shares
29 Apr 2021	Form 3: Evans Thomas George, Chief Scientific Officer Holds 127,926 shares of Ordinary Shares
29 Apr 2021	Form 3: Enright William, Director Holds 743,454 shares of Ordinary Shares
29 Apr 2021	Form 3: Ellis Christopher, Chief Operating Officer
29 Apr 2021	Form 3: Egorov Georgy, Chief Financial Officer
29 Apr 2021	Form 3: Griffiths Graham, Chief Business Officer
29 Apr 2021	Form 3: Dawes Karen A, Director No securities owned

Comments